Nyxoah
1 known investors
Nyxoah develops the Genio system, a leadless and battery-free hypoglossal neurostimulation therapy to treat obstructive sleep apnea (OSA). The company targets patients with OSA, a common sleep-disordered breathing condition affecting hundreds of millions globally.
HealthtechMedical Devices